DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Solithromycin is an investigational drug.
There have been 11 clinical trials for Solithromycin. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2013.
The most common disease conditions in clinical trials are Pneumonia, Bacterial, Pneumonia, and Gonorrhea. The leading clinical trial sponsors are Cempra Inc, National Institute of Allergy and Infectious Diseases (NIAID), and Department of Health and Human Services.
There are one hundred and six US patents protecting this investigational drug and eight hundred and eighteen international patents.
Recent Clinical Trials for Solithromycin
|Safety and Efficacy of Solithromycin in Adolescents and Children With Community-acquired Bacterial Pneumonia||Cempra Inc||Phase 2/Phase 3|
|Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis||Cempra Inc||Phase 2|
|A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease||Cempra Inc||Phase 2|
Top disease conditions for Solithromycin
Top clinical trial sponsors for Solithromycin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Solithromycin||Get Started Free||Anti-CS1 antibodies and antibody drug conjugates||AbbVie Biotherapeutics Inc. (Redwood City, CA)||Get Started Free|
|Solithromycin||Get Started Free||Hamamelitannin analogues and uses thereof||UNIVERSITEIT GENT (Ghent, BE)||Get Started Free|
|Solithromycin||Get Started Free||Pharmaceutical composition for the treatment of multi-drug resistant infections||Council of Scientific & Industrial Research (New Delhi, IN)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Solithromycin||Australia||AU2015339012||2034-10-31||Get Started Free|
|Solithromycin||Brazil||BR112017008945||2034-10-31||Get Started Free|
|Solithromycin||Canada||CA2966005||2034-10-31||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|